Clinical Trial: Triple Versus Quadruple Therapy for the Eradication of Helicobacter Pylori

U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06299605) titled 'Triple Versus Quadruple Therapy for the Eradication of Helicobacter Pylori' on Feb. 19.

Brief Summary: The study aimed to compare the efficacy and safety of 7-day and 14-day vonoprazan-amoxicillin-tetracycline triple therapy with 14-day vonoprazan-amoxicillin-tetracycline-bismuth quadruple therapy for the eradication of Helicobacter pylori. Subjects were randomized to receive the intervention and were reviewed by 13C-urea breath test after 6 weeks. The eradication rates, adverse reaction rates and patient adherence were calculated.

Study Type: Interventional

Condition: Helicobacter Pylori Infection

Intervention: * Drug: Vonopraza...